First New York Securities’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

First New York Securities’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-11	Closed	-$55	–	619
2015 Q1	$55	Buy	+11	New	+$1.61K	﹤0.01%	375

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

First New York Securities's SLXP Position: Q2 2015 in Review

First New York Securities sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 98,099 shares — an estimated $17M sold.

First New York Securities first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $17M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

First New York Securities reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
First New York Securities sold 98,099 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $17M.
First New York Securities first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
First New York Securities's SALIX PHARMACEUTICALS LTD DEL position peaked at $17M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on First New York Securities's 13F filing for Q2 2015, filed 30 Jul 2015.